Last reviewed · How we verify

NCT04320927

Iatrogenic Withdrawal Symptoms in Severe Traumatic Brain Injury

Status unknown Last updated 27 April 2020
What this trial tests

trial in Iatrogenic Withdrawal Symptomes in 215 participants. Status unknown.

Timeline
1 March 2020
Primary endpoint
1 August 2020
1 August 2020

Quick facts

Lead sponsorRigshospitalet, Denmark
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment215
Start date1 March 2020
Primary completion1 August 2020
Estimated completion1 August 2020
Sites1 location across Denmark

Conditions studied

Sponsor

Rigshospitalet, Denmark

Who can join

18 and older, any sex, with Iatrogenic Withdrawal Symptomes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Iatrogenic withdrawal symptomes has been associated with prolonged mechanical ventilation and the and the derived symptoms such as fever and agitation has been shown to cause significantly prolonged ICU and hospital length of stay. The incidence of IWS in the adult general ICU ranges from 16,7-55%. To this date, the incidence of IWS has not been studied in patients with TBI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04320927.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing